These novel medications , including Semaglutide , Mounjaro , and Retatrutide , represent a important advancement in addressing type 2 diabetes and supporting weight reduction . They function by imitating the body’s natural peptide GLP-1 , enabling to moderate blood sugar and lower appetite . The